ASCO 2025: Zanidatamab plus chemotherapy shows strong first-line efficacy in HER2-positive gastro-oesophageal adenocarcinoma
A phase 2 trial reports high response rates and durable outcomes in treatment-naive patients, presented…
Browsing: Featured News
Paediatric investigation study identifies immune drivers of medulloblastoma metastasis using explainable AI
Medulloblastoma, the most common malignant paediatric brain tumour, presents substantial clinical challenges due to its…
AI could help improve early detection of interval breast cancers
A new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center suggests that…
Cancer Council Victoria’s statewide Bowel Screening Campaign results
Analysis undertaken by the Daffodil Centre shows an additional 25,080 Victorians completed and returned a…
SALSA: A new artificial intelligence tool for the automated and precise analysis of liver tumours
Investigators of the Vall d’Hebron Institute of Oncology’s (VHIO) Radiomics Group, Spain, led by Raquel…
Lower screening age calls for more tailored bowel cancer surveillance
Australia’s recent move to lower the starting age for bowel (colorectal) cancer screening from 50…
“Chimaeric RNA” opens door to treatments tailored for specific patient populations
Prostate cancer has distinct genetic properties in different groups of men that can be targeted to…
Statins may improve survival for some blood cancers
Patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who were taking cholesterol-lowering…
Pinworm medication has potential to treat Merkel cell carcinoma
A common pinworm medication may stop and reverse cancer growth in Merkel cell carcinoma, according…
DNA origami guides new possibilities in pancreatic cancer
One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s…